Leapcure logo


Beta thalassemia is a genetic blood disorder characterized by reduced or absent production of beta-globin chains in hemoglobin, leading to ineffective red blood cell production and anemia. The severity of symptoms can vary from mild to severe, depending on the specific genetic mutations involved. Treatment may involve blood transfusions, iron chelation therapy to manage iron overload, and in some cases, bone marrow transplantation or gene therapy to address the underlying genetic defect.

Beta Thalassemia Patient

Register for our Patient Community to hear about current and upcoming studies.

Register for Studies

Patient Advocacy Groups

Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.

Related Posts

Join the community

Add your voice to the research conversation